Overview

Therapeutic Study of ONO-4819CD for Ulcerative Colitis

Status:
Terminated
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate whether ONO-4819CD is safe and effective in the treatment of mild to moderate ulcerative colitis.
Phase:
Phase 2
Details
Lead Sponsor:
Kyoto University, Graduate School of Medicine
Collaborator:
National Institute of Biomedical Innovation